4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-043647
Chief Executive Officer sold 150,000 shares at an average $18.35 ($2,752,163)
From the SEC's structured data for this filing
Trades in this filing
Santos da Silva Jorge · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-10 | Sale : show line 1 in the form | −98,127 | $18.41 | $1,806,518 | 2,976,766 | D |
| 2026-04-13 | Sale : show line 2 in the form | −51,873 | $18.23 | $945,645 | 2,924,893 | D |
| Open-market sales · 150,000 sh · avg $18.35 · $2,752,163 | ||||||
Loading xslF345X06/ownership.xml…